Sphistin (12-38)

General Information


DCTPep ID  DCTPep00722

Peptide Name   Sphistin (12-38)

Sequence  KAKAKAVSRSARAGLQFPVGRIHRHLK

Sequence Length  27

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer therapy related peptides



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Not active up to 100 µg/ml MTS assay 24h 1

Hemolytic Activity  Crab haemocytes: Not active up to 100 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep00722

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C132H228N48O31

Absent amino acids  CDEMNTWY

Theoretical pI  12.48

Acidic residues  0

Basic residues  10

Polar residues  4

Molecular weight (Average)  2983.57

Molecular weight (Monoisotopic)  2981.77

Common amino acids  A

Net charge  10

Instability index (II)  62

Aliphatic index  83.33

Grand average of hydropathicity (GRAVY)  -0.563

Half Life 
  1.3 hours (mammalian reticulocytes, in vitro).
  3 min (yeast, in vivo).
  3 min (Escherichia coli, in vivo).

Extinction coefficients 
  Should not be visible by UV spectrophotometry.

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28600196

Title  A truncated Sph12-38 with potent antimicrobial activity showing resistance against bacterial challenge in Oryzias melastigma

Doi 10.1016/j.fsi.2017.06.013

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.